IL55433A - Method for isolating and purifying polyribosyl ribitol phosphate from haemophilus influenzae and a vaccine comprising it together with bordetella pertussis antigens - Google Patents

Method for isolating and purifying polyribosyl ribitol phosphate from haemophilus influenzae and a vaccine comprising it together with bordetella pertussis antigens

Info

Publication number
IL55433A
IL55433A IL55433A IL5543378A IL55433A IL 55433 A IL55433 A IL 55433A IL 55433 A IL55433 A IL 55433A IL 5543378 A IL5543378 A IL 5543378A IL 55433 A IL55433 A IL 55433A
Authority
IL
Israel
Prior art keywords
vaccine
purifying
isolating
haemophilus influenzae
bordetella pertussis
Prior art date
Application number
IL55433A
Other versions
IL55433A0 (en
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/846,466 external-priority patent/US4196192A/en
Priority claimed from US05/846,488 external-priority patent/US4220717A/en
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of IL55433A0 publication Critical patent/IL55433A0/en
Publication of IL55433A publication Critical patent/IL55433A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL55433A 1977-10-28 1978-08-25 Method for isolating and purifying polyribosyl ribitol phosphate from haemophilus influenzae and a vaccine comprising it together with bordetella pertussis antigens IL55433A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/846,466 US4196192A (en) 1977-10-28 1977-10-28 Combined Haemophilus influenzae type b and pertussis vaccine
US05/846,488 US4220717A (en) 1977-12-22 1977-12-22 Isolation and purification of polyribosyl ribitol phosphate from Haemophilus influenzae type b.

Publications (2)

Publication Number Publication Date
IL55433A0 IL55433A0 (en) 1978-10-31
IL55433A true IL55433A (en) 1982-09-30

Family

ID=27126641

Family Applications (1)

Application Number Title Priority Date Filing Date
IL55433A IL55433A (en) 1977-10-28 1978-08-25 Method for isolating and purifying polyribosyl ribitol phosphate from haemophilus influenzae and a vaccine comprising it together with bordetella pertussis antigens

Country Status (25)

Country Link
JP (1) JPS5480408A (en)
AR (1) AR218932A1 (en)
AU (1) AU520902B2 (en)
BE (1) BE871586A (en)
CA (1) CA1117866A (en)
CH (1) CH649781A5 (en)
DD (1) DD140701A5 (en)
DE (1) DE2845745A1 (en)
DK (1) DK154327C (en)
ES (1) ES474611A1 (en)
FI (1) FI63674C (en)
FR (1) FR2407000B1 (en)
GB (1) GB2007244B (en)
GR (1) GR73991B (en)
HU (1) HU178166B (en)
IE (1) IE47474B1 (en)
IL (1) IL55433A (en)
IT (1) IT1107570B (en)
NL (1) NL7810753A (en)
NO (1) NO149611C (en)
NZ (1) NZ188211A (en)
PH (1) PH15882A (en)
PL (1) PL210545A1 (en)
SE (1) SE430753B (en)
YU (1) YU250878A (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE889979A (en) * 1981-08-14 1982-02-15 Smith Kline Rit PROCESS FOR THE PREPARATION OF PURIFIED ANTIGENIC CAPSULAR BACTERIAL POLYSACCHARIDES, PRODUCTS OBTAINED AND THEIR USE
CA1209036A (en) * 1982-08-20 1986-08-05 Joseph S.C. Kuo Combined haemophilus influenzae and diphtheria, pertussis, tetanus vaccine
US4744982A (en) * 1982-08-24 1988-05-17 Hunter Kenneth W Human monoclonal antibody reactive with polyribosylribitol phosphate
EP0471177B1 (en) * 1990-08-13 1995-10-04 American Cyanamid Company Filamentous hemagglutinin of bordetella pertussis as a carrier molecule for conjugate vaccines
SK18594A3 (en) * 1991-08-16 1994-08-10 Merck & Co Inc Method of production of capsular polysacharide without lipid and endotoxine

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3395219A (en) * 1964-12-11 1968-07-30 Merck & Co Inc Process for production of pertussis antigen
IL24946A (en) * 1965-01-19 1969-05-28 Merck & Co Inc Process for preparing b. pertussis antigens
US3465078A (en) * 1965-10-21 1969-09-02 Sydney Z Spiesel Method of recovering antigens from bordetella pertussis cells
NL174267B (en) * 1969-05-20 Roussel Uclaf IMPROVEMENT OF THE PROCESS FOR THE PREPARATION OF A SOMATIC ANTIGEN ACCORDING TO DUTCH PATENT 169754 AND PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION.
US3636192A (en) * 1970-01-13 1972-01-18 Us Army Meningococcal polysaccharide vaccines
FR2253499B1 (en) * 1973-12-10 1977-11-04 Fabre Sa Pierre
DE2461439C3 (en) * 1974-12-24 1980-03-20 Behringwerke Ag, 3550 Marburg Process for the preparation of a protective antigen from Bordetella pertussis and agent containing the same
US3978209A (en) * 1975-03-24 1976-08-31 Merck & Co., Inc. Endotoxin free meningococcus polysaccharides

Also Published As

Publication number Publication date
DK154327C (en) 1989-04-03
GR73991B (en) 1984-06-06
NO149611B (en) 1984-02-13
BE871586A (en) 1979-04-27
FR2407000B1 (en) 1983-01-21
AU4108178A (en) 1980-05-01
DK479578A (en) 1979-04-29
GB2007244A (en) 1979-05-16
PL210545A1 (en) 1980-02-25
IL55433A0 (en) 1978-10-31
ES474611A1 (en) 1980-01-16
JPS5480408A (en) 1979-06-27
CH649781A5 (en) 1985-06-14
AU520902B2 (en) 1982-03-04
IE47474B1 (en) 1984-03-21
NL7810753A (en) 1979-05-02
DD140701A5 (en) 1980-03-26
NZ188211A (en) 1984-09-28
FI783269A (en) 1979-04-29
CA1117866A (en) 1982-02-09
FI63674B (en) 1983-04-29
GB2007244B (en) 1982-03-31
NO783635L (en) 1979-05-02
SE430753B (en) 1983-12-12
DE2845745C2 (en) 1987-10-01
AR218932A1 (en) 1980-07-15
DE2845745A1 (en) 1979-05-10
NO149611C (en) 1984-05-23
IE782146L (en) 1979-04-28
YU250878A (en) 1983-12-31
HU178166B (en) 1982-03-28
FI63674C (en) 1983-08-10
PH15882A (en) 1983-04-13
JPS6231694B2 (en) 1987-07-09
FR2407000A1 (en) 1979-05-25
DK154327B (en) 1988-11-07
IT1107570B (en) 1985-11-25
IT7851621A0 (en) 1978-10-24
SE7811192L (en) 1979-04-29

Similar Documents

Publication Publication Date Title
EP0121249A3 (en) Method for the production of ha fraction containing protective antigens of bordetella pertussis and pertussis vaccine
PH15958A (en) Isolation and purification of polyribosyl ribitol phosphate from haemophilus influenzae type b
DE2962411D1 (en) Method for preparing magnesium hydrides
GB2064499B (en) Method of making a shaped silicon carbide-silicon matrix composite
GB2063646B (en) Method of making lined elastomeric article
JPS55139816A (en) Method of separating gas
IL98233A0 (en) Efficacious vaccines against bordetella pertussis comprising a combination of individually purified pertusis antigens
ZA807150B (en) Cryogenic expander recovery process
IL55433A (en) Method for isolating and purifying polyribosyl ribitol phosphate from haemophilus influenzae and a vaccine comprising it together with bordetella pertussis antigens
ZA784324B (en) High molecular weight meningococcal group c vaccine and method for preparation thereof
PH18636A (en) Method of purifying nucleolar antigens
GB2082188B (en) Immobilized aminoacylase preparation and method for producing thereof
GB2057194B (en) Method of producing a permanent anisotropic magnet
JPS55144401A (en) Method of producing synthetic gas for ammonia preparation
GB2065473B (en) Process for producing hepatitis b vaccine
ES8401722A1 (en) Haemophilus influenzae type B and pertussis outer membrane component combined vaccine.
GB2102291B (en) Method for purifying polyosides of streptococcus pneumoniae and vaccine based on polyosides thus purified
JPS5672697A (en) Recovery of xanthane gum
IL90994A0 (en) Bordetella pertussis vaccine
GB2050851B (en) Method for the recovery of acetone
JPS55134603A (en) Method of recovering gas
JPS55163101A (en) Method of charging
GB2051040B (en) Processes for preparing and recovering n-alkylethylenediamines
BG34432A1 (en) Method for producing anisotropic permanent magnets
ZA805123B (en) A method of lining a pipe